SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,770.00    75.00 (1.12%)
Bid:
6,765.00
Ask:
6,775.00
Spread: 10.00 (0.148%)
Market Cap: £5.00b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

3 Apr 2017 07:30

RNS Number : 2765B
Spirax-Sarco Engineering PLC
03 April 2017
 

 

3rd April 2017

Acquisition of Gestra for €186 million (£160 million)

Spirax-Sarco Engineering plc (Spirax Sarco), which specialises in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has signed a conditional sale and purchase agreement to acquire Gestra AG and associated businesses (Gestra) from Flowserve Corporation for a cash-free, debt-free consideration of €186 million (£160 million). 

Gestra, which has its headquarters in Bremen, Germany, is a technology leader in advanced industrial boiler control systems and specialises in the design and production of valves and control systems for steam and fluid process control.

In 2016, Gestra recorded revenues of €92.5 million (£79.7 million), EBITDA of €16.6 million (£14.3 million) and EBIT of €15.2 million (£13.1 million). Approximately 80% of the company's revenues are in Europe with the balance spread roughly evenly between the Americas and Asia Pacific. 

At 31st December 2016, Gestra's gross assets were €66.8 million (£57.6 million). 

Gestra is highly complementary to the Spirax Sarco Steam Specialties business and will enhance and accelerate the implementation of Spirax Sarco's strategy for growth, as a result of its well-developed capabilities in a wide range of industries and applications.

Due to its strong brand, Gestra will be operated alongside the Spirax Sarco Steam Specialties business, targeting global growth in its key market sectors through the co-ordinated application of the knowledge and strengths of both businesses. Spirax Sarco will invest in Gestra's product and market development to extend its world-leading customer value proposition to an enlarged addressable market. 

The purchase consideration will be financed from a combination of existing cash resources and debt facilities. The acquisition will be accretive to Group earnings in 2017 but is expected to have a slightly dilutionary impact on the Group profit margin in this year.

Completion is subject to certain customary conditions, including regulatory approval of the transaction by the merger control authority in Germany. These conditions are expected to be satisfied during the current quarter. 

Nicholas Anderson, Chief Executive of Spirax-Sarco Engineering plc, said;

"We are delighted to be bringing Gestra, its management and employees into the Spirax Sarco family. Our businesses are highly complementary; Gestra will enhance the market and product offering of Spirax Sarco and will benefit from our global footprint and broader product range. We believe that this combination will deliver enhanced value to both customers and shareholders".

There will be a hosted conference call, including Q&A, for investors and analysts at 9.30am UK time today. Dial-in numbers are UK Toll Free 0808 109 0700 and for Standard International Access +44 20 3003 2666. Please use the password 'Spirax-Sarco'.

 

 

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

Spirax-Sarco Engineering plc comprises two niche businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for peristaltic pumps and associated fluid path technologies. The Steam Specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The Company helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 5,300 people, of whom nearly 1,400 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAELAEENXEAF
Date   Source Headline
22nd May 20139:14 amRNSDirector/PDMR Shareholding
9th May 20134:22 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 20139:42 amRNSTotal Voting Rights
1st May 20138:53 amRNSChange of Director Details
18th Apr 20133:51 pmRNSHolding(s) in Company
12th Apr 20138:48 amRNSDirector/PDMR Shareholding
10th Apr 201311:01 amRNSDirector/PDMR Shareholding Replacement
10th Apr 20138:50 amRNSDirector/PDMR Shareholding
2nd Apr 201312:39 pmRNSTotal Voting Rights
22nd Mar 20139:41 amRNSAnnual Financial Report
19th Mar 20133:28 pmRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSDirector/PDMR Shareholding
7th Mar 20137:00 amRNSFinal Results 2012
6th Mar 20132:03 pmRNSTotal Voting Rights
26th Feb 20133:30 pmRNSDirector Declaration
5th Feb 20139:37 amRNSTotal Voting Rights
2nd Jan 20133:54 pmRNS2013 Key Dates
2nd Jan 20133:54 pmRNSTotal Voting Rights
2nd Jan 20133:54 pmRNSDirector/PDMR Shareholding
21st Dec 20125:21 pmRNSDirector/PDMR Shareholding
14th Dec 20129:07 amRNSDirector/PDMR Shareholding
6th Dec 20122:58 pmRNSDirector/PDMR Shareholding
3rd Dec 20124:03 pmRNSTotal Voting Rights
15th Nov 20128:25 amRNSHolding(s) in Company
8th Nov 20123:52 pmRNSHolding(s) in Company
7th Nov 20129:30 amRNSAcquisition
7th Nov 20127:00 amRNSInterim Management Statement
2nd Nov 20122:16 pmRNSTotal Voting Rights
23rd Oct 20123:19 pmRNSHolding(s) in Company
18th Oct 20124:36 pmRNSHolding(s) in Company
12th Oct 20122:38 pmRNSDirector/PDMR Shareholding
11th Oct 201210:51 amRNSDirector/PDMR Shareholding
11th Oct 201210:50 amRNSHolding(s) in Company
1st Oct 201211:30 amRNSTotal Voting Rights
28th Sep 201210:25 amRNSHolding(s) in Company
24th Sep 20122:28 pmRNSHolding(s) in Company
3rd Sep 20123:11 pmRNSTotal Voting Rights
30th Aug 20124:00 pmRNSHolding(s) in Company
22nd Aug 20127:00 amRNSSpirax Sarco Plc Interim Results 2012
1st Aug 201211:21 amRNSTotal Voting Rights
1st Aug 201211:20 amRNSHolding(s) in Company
25th Jul 201210:00 amRNSDates for 2012 Half-Year Results
17th Jul 20123:56 pmRNSHolding(s) in Company
16th Jul 201210:00 amRNSBoard Appointment
5th Jul 201212:05 pmRNSChange of Director Details
3rd Jul 20124:54 pmRNSTotal Voting Rights
1st Jun 201212:35 pmRNSTotal Voting Rights
31st May 20128:27 amRNSHolding(s) in Company
25th May 201210:42 amRNSResult of AGM - Replacement Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.